Home
Conditions
Prostatic Neoplasms

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,735 public trials 964 recruiting studies

Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Active, Not Recruiting

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

NCT04644770

Conditions: Adenocarcinoma, Carcinoma, Genital Diseases, +11 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

City of Hope Duarte, California, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

University of Chicago Chicago, Illinois, United States

View Trial Details

Active, Not Recruiting

Intraprostatic Anesthesia During Transperineal Prostate Biopsy

NCT07683182

Conditions: Disease, Genital Diseases, Genital Diseases, Male, +12 more
Locations: Marmara University School of Medicine Istanbul, Pendik, Turkey (Türkiye)

View Trial Details

Active, Not Recruiting

A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

NCT03127631

Conditions: Cardiovascular Disease, Cardiovascular Diseases, Genital Diseases, +10 more
Locations: Georgia Cancer Center at Augusta University Augusta, Georgia, United States

University of Kansas Medical Center Kansas City, Kansas, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

UT Southwestern Medical Center Dallas, Texas, United States

View all 61 locations

View Trial Details

Active, Not Recruiting

Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer

NCT04989946

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Active, Not Recruiting

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

NCT05628363

Conditions: Cancer of the Prostate, Genital Diseases, Genital Diseases, Male, +9 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Active, Not Recruiting

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

NCT07118176

Conditions: Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +127 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

NCT05288166

Conditions: Abiraterone Acetate, Androgens, Antineoplastic Agents, +27 more
Locations: Arizona Oncology Associates, P.C. - HOPE Prescott, Arizona, United States

Arizona Oncology Associates, P.C. - HOPE Prescott Valley, Arizona, United States

The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States

Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States

View all 266 locations

View Trial Details

Active, Not Recruiting

Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)

NCT04788277

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer

NCT03624660

Conditions: Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +8 more
Locations: University of Florida Health Proton Therapy Institute Jacksonville, Florida, United States

View Trial Details

Active, Not Recruiting

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

NCT02692105

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: British Columbia Cancer Agency Center for the Southern Interior Kelowna, British Columbia, Canada

View Trial Details

Prostatic Neoplasms

Prostatic Neoplasms trial results

Related conditions